A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Blood

• Publication date

  2011-11-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2011-01-329656PMID 21908423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T Cells

  2011cited by this paper
• Prolonged Antigen Storage Endows Merocytic Dendritic Cells with Enhanced Capacity To Prime Anti-Tumor Responses in Tumor-Bearing Mice

  2010cited by this paper
• DNA vaccines against cancer come of age.

  2010cited by this paper
• FOXP3+ regulatory T cells in the human immune system

  2010cited by this paper
• Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs

  2010cited by this paper
• Mechanisms maintaining peripheral tolerance

  2010cited by this paper
• T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

  2009cited by this paper
• Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

  2009cited by this paper
• Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

  2009cited by this paper
• Toward the Discovery of Vaccine Adjuvants: Coupling In Silico Screening and In Vitro Analysis of Antagonist Binding to Human and Mouse CCR4 Receptors

  2009cited by this paper
• Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

  2009cited by this paper
• Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice.

  2009cited by this paper
• Comparative methodologies of regulatory T cell depletion in a murine melanoma model.

  2008cited by this paper
• Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

  2008cited by this paper
• The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.

  2008cited by this paper
• How regulatory T cells work

  2008cited by this paper
• Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients

  2008cited by this paper
• In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination

  2008cited by this paper
• CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells

  2007cited by this paper
• Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease

  2007cited by this paper
• CCR4-dependent regulatory T cell function in inflammatory bowel disease

  2007cited by this paper
• Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy

  2007cited by this paper
• IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.

  2007cited by this paper
• Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4+ Tregs and Unprimed CCR4− Tregs, Regulate Effector T Cells Using FasL1

  2007cited by this paper
• Human Dendritic Cells Acquire a Semimature Phenotype and Lymph Node Homing Potential through Interaction with CD4+CD25+ Regulatory T Cells1

  2007cited by this paper
• B Subunit of Shiga Toxin-Based Vaccines Synergize with α-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity1

  2007cited by this paper
• Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells

  2007cited by this paper
• Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells.

  2007cited by this paper
• Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4 Tregs and Unprimed CCR4 Tregs, Regulate Effector T Cells Using FasL

  2007cited by this paper
• Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo

  2006cited by this paper
• Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.

  2006cited by this paper
• The Majority of Human Peripheral Blood CD4+CD25highFoxp3+ Regulatory T Cells Bear Functional Skin-Homing Receptors1

  2006cited by this paper
• Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.

  2006cited by this paper
• The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity

  2006cited by this paper
• Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

  2006cited by this paper
• Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo.

  2006cited by this paper
• CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.

  2005cited by this paper
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

  2005cited by this paper
• CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.

  2005cited by this paper
• A peripheral circulating compartment of natural naive CD4 Tregs.

  2005cited by this paper
• Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.

  2005cited by this paper
• Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor

  2005cited by this paper
• Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

  2005cited by this paper
• Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

  2004cited by this paper
• Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance.

  2004cited by this paper
• CD4+ CD25+ Regulatory T Cells Control T Helper Cell Type 1 Responses to Foreign Antigens Induced by Mature Dendritic Cells In Vivo

  2003cited by this paper
• Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells

  2001cited by this paper
• The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens1

  2000cited by this paper

• Targeting cytokines: Reshaping the pancreatic tumor microenvironment.

  2025cites this paper
• HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine

  2025cites this paper
• Regulatory T Cells in Tumor Microenvironment: Therapeutic Approaches and Clinical Implications

  2025cites this paper
• Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination

  2024cites this paper
• Single-cell transcriptomics reveals comprehensive microenvironment and highlights the dysfuntional state of NK cells in endometrioid carcinoma

  2024cites this paper
• Identification of novel cytokine to judge the diagnosis and clinical phenotype of adult-onset Still’s disease

  2024cites this paper
• Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects

  2024cites this paper
• Targeting cytokine and chemokine signaling pathways for cancer therapy

  2024cites this paper
• Immunostimulatory effects of Toll‐like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris

  2024cites this paper
• Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity.

  2024cites this paper
• Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers

  2024cites this paper
• Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options.

  2023cites this paper
• The Effect of Iontophoretic-Delivered Polyplex Vaccine on Melanoma Regression.

  2023cites this paper
• Engineered Synthetic STxB for Enhanced Cytosolic Delivery

  2023cites this paper
• Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma

  2023cites this paper
• Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy

  2023cites this paper
• STxB as an Antigen Delivery Tool for Mucosal Vaccination

  2022cites this paper
• CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors

  2021cites this paper
• Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?

  2021cites this paper
• Tumor resident regulatory T cells.

  2021cites this paper
• Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma

  2021cites this paper
• CCR4 as a Therapeutic Target for Cancer Immunotherapy

  2021cites this paper
• The Cellular and Chemical Biology of Endocytic Trafficking and Intracellular Delivery—The GL–Lect Hypothesis

  2021cites this paper
• DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor

  2021cites this paper
• Key chemokines direct migration of immune cells in solid tumors

  2021cites this paper
• Single-cell RNA sequencing reveals a novel cell type and immunotherapeutic 1 targets in papillary thyroid cancer

  2021cites this paper
• Updating targets for natural killer/T-cell lymphoma immunotherapy

  2021cites this paper
• Small Molecule CCR4 Antagonists Protect Mice from Aspergillus Infection and Allergy

  2021cites this paper
• Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

  2020cites this paper
• Dormant tumor cells interact with memory CD8+ T cells in RET transgenic mouse melanoma model.

  2020cites this paper
• CCL22 Signaling in the Tumor Environment.

  2020cites this paper
• Regulatory T Cells in Cancer

  2020cites this paper
• Inducers, Attractors and Modulators of CD4+ Treg Cells in Non-Small-Cell Lung Cancer

  2020cites this paper
• A novel methodology of the myeloid-derived suppressor cells (MDSCs) generation with splenic stroma feeder cells.

  2020cites this paper
• Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma

  2020cites this paper
• DNA Methylation in Anti-cancer Effects of Dietary Catechols and Stilbenoids: An Overview of Underlying Mechanisms

  2019cites this paper
• Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers

  2019cites this paper
• Recent Advances of Small Molecular Regulators Targeting G Protein-Coupled Receptors Family for Oncology Immunotherapy.

  2019cites this paper
• Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.

  2019cites this paper
• A transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages

  2019cites this paper
• Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies

  2019cites this paper
• CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes

  2019cites this paper
• Umbilical cord blood-derived Helios-positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA-VEGFR2 pathway

  2019cites this paper
• The role of T helper 17 and regulatory T cells in tumor microenvironment

  2019cites this paper
• Therapeutic cancer vaccine: building the future from lessons of the past

  2018cites this paper
• Strategies to Reduce Intratumoral Regulatory T Cells

  2018cites this paper
• Ccl17-dependent release of Ccl3 restrains regulatory T cells thereby aggravating atherosclerosis

  2018cites this paper
• Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles

  2018cites this paper
• A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.

  2018cites this paper
• Plasmacytoid DC/Regulatory T Cell Interactions at the Center of an Immunosuppressive Network in Breast and Ovarian Tumors

  2018cites this paper
• Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice

  2018cites this paper
• Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

  2018cites this paper
• Fingolimod can act as a facilitator to establish the primary T-cell response with reduced need of adjuvants.

  2018cites this paper
• Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.

  2017cites this paper
• Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells

  2017cites this paper
• Multipeptide-coupled nanoparticles induce tolerance in ‘humanised’ HLA-transgenic mice and inhibit diabetogenic CD8+ T cell responses in type 1 diabetes

  2017cites this paper
• Molecular adjuvants that modulate regulatory T cell function in vaccination: A critical appraisal

  2017cites this paper
• RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity In Vivo

  2017cites this paper
• Harnessing the regulators to enhance viral vaccine efficacy.

  2017cites this paper
• Le microenvironnement immunitaire des Carcinomes épidermoides de la cavité orale

  2017cites this paper
• CCR4 is a determinant of melanoma brain metastasis

  2017cites this paper
• Selective expansion of human regulatory T cells in nasal polyps, and not adjacent tissue microenvironments, in individual patients exposed to steroids.

  2017cites this paper
• In Silico Adjuvant Design and Validation.

  2017cites this paper
• Immunomodulatory Activity of VEGF in Cancer.

  2017cites this paper
• Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.

  2017cites this paper
• Evaluation of novel anti-tumoral strategies using peptide or monoclonal antibody immunotherapies

  2016cites this paper
• Induction of unconventional T cells by a mutant BCG strain formulated in

  2016cites this paper
• A Therapeutic Her2/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/neu–Expressing Tumor in HLA-A2 Transgenic Mice

  2016cites this paper
• The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine.

  2016cites this paper
• Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors

  2016cites this paper
• A therapeutic Her 2 / neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her 2 / neu-expressing tumor in HLA-A 2 transgenic mice

  2016cites this paper
• CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.

  2016cites this paper
• CELL LEVELS ORACTIVITY FOR TREATMENT OF ALZHEMERS DISEASE

  2016cites this paper
• Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors.

  2016cites this paper
• Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice

  2016cites this paper
• Pharmacological opportunities to control inflammatory diseases through inhibition of the leukocyte recruitment.

  2016cites this paper
• Targeting regulatory T cells in tumors

  2016cites this paper
• 2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis.

  2016cites this paper
• Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

  2016cites this paper
• CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

  2016cites this paper
• Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity

  2016cites this paper
• Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literature

  2016cites this paper
• Immune Response Regulation has Therapeutic Potential in the Treatment of Cancer

  2015cites this paper
• C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer

  2015cites this paper
• Immunosuppression associated with chronic inflammation in the tumor microenvironment.

  2015cites this paper
• Frequency, Suppressive Capacity, Recruitment and Induction Mechanisms of Regulatory T Cells in Sinonasal Squamous Cell Carcinoma and Nasal Inverted Papilloma

  2015cites this paper
• Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma

  2015cites this paper
• The effects of globotriaosylceramide tail saturation level on bilayer phases.

  2015cites this paper
• CCR4 and its ligands: from bench to bedside.

  2015cites this paper
• Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.

  2015cites this paper
• Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway.

  2015cites this paper
• Computational modelling approaches to vaccinology.

  2015cites this paper
• [HPV (Human Papilloma Virus) implication in other cancers than gynaecological].

  2015cites this paper
• Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites

  2015cites this paper
• Etude de l’immunité anti-tumorale à long-terme induite par traitement par un anticorps anti-CD20 de souris porteuses de tumeur

  2015cites this paper
• Role and prognostic importance of regulatory T cells in lung cancer patients, according to the presence of tertiary lymphoid structures

  2015cites this paper
• Impact des inhibiteurs de la voie mTOR sur la réponse immunitaire T anti-tumorale

  2015cites this paper
• Optimisation d'un vaccin thérapeutique dans les tumeurs des voies aérodigestives supérieures associées aux papillomavirus : rôle de l'induction d'une immunité muqueuse et de la combinaison à la radiothérapie

  2015cites this paper
• Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients

  2015cites this paper
• Retrograde transport is not required for cytosolic translocation of the B-subunit of Shiga toxin

  2015cites this paper